Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ)
CNY 4.67
(-0.21%)
CNY 4.67
(-0.21%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -464.24 Million CNY | -293.12% |
| 2022 | 240.38 Million CNY | 96.97% |
| 2021 | 122.04 Million CNY | -69.12% |
| 2020 | 395.26 Million CNY | -56.98% |
| 2019 | 918.82 Million CNY | 29.26% |
| 2018 | 710.85 Million CNY | 77.86% |
| 2017 | 399.67 Million CNY | 22.13% |
| 2016 | 327.26 Million CNY | -46.63% |
| 2015 | 613.16 Million CNY | 899.57% |
| 2014 | 61.34 Million CNY | 159.72% |
| 2013 | -102.71 Million CNY | -3189.52% |
| 2012 | 3.32 Million CNY | -97.25% |
| 2011 | 120.88 Million CNY | 21.09% |
| 2010 | 99.83 Million CNY | 193.32% |
| 2009 | 34.03 Million CNY | 14.38% |
| 2008 | 29.75 Million CNY | -37.67% |
| 2007 | 47.73 Million CNY | -35.55% |
| 2006 | 74.06 Million CNY | -4.23% |
| 2005 | 77.32 Million CNY | 49.9% |
| 2004 | 51.58 Million CNY | 57.94% |
| 2003 | 32.66 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 6.19 Million CNY | -78.64% |
| 2024 Q3 | -33.49 Million CNY | -640.4% |
| 2024 Q1 | 29 Million CNY | 106.91% |
| 2023 Q2 | -26.4 Million CNY | -159.6% |
| 2023 Q1 | 44.29 Million CNY | 134.99% |
| 2023 Q4 | -419.88 Million CNY | -574.45% |
| 2023 FY | -464.24 Million CNY | -293.12% |
| 2023 Q3 | -62.25 Million CNY | -135.8% |
| 2022 Q3 | 78.92 Million CNY | -18.76% |
| 2022 Q1 | 100.18 Million CNY | 264.58% |
| 2022 FY | 240.38 Million CNY | 96.97% |
| 2022 Q4 | -126.61 Million CNY | -260.42% |
| 2022 Q2 | 97.14 Million CNY | -3.04% |
| 2021 Q4 | 27.48 Million CNY | 23.06% |
| 2021 FY | 122.04 Million CNY | -69.12% |
| 2021 Q1 | 71.08 Million CNY | 289.84% |
| 2021 Q2 | 1.14 Million CNY | -98.39% |
| 2021 Q3 | 22.33 Million CNY | 1851.71% |
| 2020 Q1 | 124.75 Million CNY | 26.83% |
| 2020 Q2 | 194.81 Million CNY | 56.16% |
| 2020 Q3 | 113.14 Million CNY | -41.92% |
| 2020 FY | 395.26 Million CNY | -56.98% |
| 2020 Q4 | -37.44 Million CNY | -133.1% |
| 2019 Q1 | 239.66 Million CNY | 59.54% |
| 2019 FY | 918.82 Million CNY | 29.26% |
| 2019 Q4 | 98.36 Million CNY | -58.44% |
| 2019 Q3 | 236.68 Million CNY | -31.22% |
| 2019 Q2 | 344.1 Million CNY | 43.58% |
| 2018 Q1 | 60.6 Million CNY | 0.35% |
| 2018 FY | 710.85 Million CNY | 77.86% |
| 2018 Q4 | 150.22 Million CNY | -36.6% |
| 2018 Q3 | 236.94 Million CNY | -9.94% |
| 2018 Q2 | 263.08 Million CNY | 334.09% |
| 2017 Q2 | 150.68 Million CNY | 10.67% |
| 2017 Q3 | 52.45 Million CNY | -65.19% |
| 2017 Q1 | 136.14 Million CNY | 180.17% |
| 2017 FY | 399.67 Million CNY | 22.13% |
| 2017 Q4 | 60.39 Million CNY | 15.15% |
| 2016 Q3 | 148.44 Million CNY | -24.29% |
| 2016 Q1 | 152.58 Million CNY | 84.27% |
| 2016 FY | 327.26 Million CNY | -46.63% |
| 2016 Q4 | -169.83 Million CNY | -214.41% |
| 2016 Q2 | 196.07 Million CNY | 28.5% |
| 2015 FY | 613.16 Million CNY | 899.57% |
| 2015 Q4 | 82.8 Million CNY | -42.64% |
| 2015 Q3 | 144.34 Million CNY | -27.18% |
| 2015 Q2 | 198.23 Million CNY | 5.56% |
| 2015 Q1 | 187.78 Million CNY | 249.22% |
| 2014 FY | 61.34 Million CNY | 159.72% |
| 2014 Q3 | 690.82 Thousand CNY | -88.7% |
| 2014 Q2 | 6.11 Million CNY | 696.73% |
| 2014 Q4 | 53.77 Million CNY | 7683.84% |
| 2014 Q1 | 767.17 Thousand CNY | 101.14% |
| 2013 Q1 | 2.62 Million CNY | 104.03% |
| 2013 Q2 | -8.04 Million CNY | -405.89% |
| 2013 Q3 | -29.71 Million CNY | -269.46% |
| 2013 Q4 | -67.58 Million CNY | -127.45% |
| 2013 FY | -102.71 Million CNY | -3189.52% |
| 2012 Q4 | -65.25 Million CNY | -636.14% |
| 2012 Q3 | -8.86 Million CNY | -130.45% |
| 2012 FY | 3.32 Million CNY | -97.25% |
| 2012 Q1 | 48.33 Million CNY | 92.48% |
| 2012 Q2 | 29.1 Million CNY | -39.78% |
| 2011 FY | 120.88 Million CNY | 21.09% |
| 2011 Q4 | 25.11 Million CNY | -7.02% |
| 2011 Q3 | 27 Million CNY | -13.53% |
| 2011 Q2 | 31.23 Million CNY | -16.78% |
| 2011 Q1 | 37.52 Million CNY | 198.58% |
| 2010 Q1 | 21.64 Million CNY | 62.31% |
| 2010 Q3 | 31.63 Million CNY | -6.9% |
| 2010 Q2 | 33.98 Million CNY | 57.03% |
| 2010 FY | 99.83 Million CNY | 193.32% |
| 2010 Q4 | 12.56 Million CNY | -60.27% |
| 2009 FY | 34.03 Million CNY | 14.38% |
| 2009 Q4 | 13.33 Million CNY | 107.7% |
| 2009 Q3 | 6.41 Million CNY | -40.77% |
| 2009 Q2 | 10.83 Million CNY | 214.73% |
| 2009 Q1 | 3.44 Million CNY | 167.43% |
| 2008 Q1 | 15.12 Million CNY | 681.78% |
| 2008 Q2 | 17.23 Million CNY | 13.95% |
| 2008 Q3 | 2.49 Million CNY | -85.53% |
| 2008 Q4 | -5.1 Million CNY | -304.81% |
| 2008 FY | 29.75 Million CNY | -37.67% |
| 2007 Q2 | 16.84 Million CNY | 13.49% |
| 2007 FY | 47.73 Million CNY | -35.55% |
| 2007 Q4 | 1.93 Million CNY | -86.28% |
| 2007 Q3 | 14.1 Million CNY | -16.25% |
| 2007 Q1 | 14.84 Million CNY | 13.09% |
| 2006 Q3 | 18.39 Million CNY | -20.15% |
| 2006 Q4 | 13.12 Million CNY | -28.65% |
| 2006 FY | 74.06 Million CNY | -4.23% |
| 2006 Q2 | 23.03 Million CNY | 18.13% |
| 2006 Q1 | 19.5 Million CNY | 6.04% |
| 2005 FY | 77.32 Million CNY | 49.9% |
| 2005 Q3 | 20.18 Million CNY | 0.0% |
| 2005 Q4 | 18.39 Million CNY | -8.91% |
| 2004 FY | 51.58 Million CNY | 57.94% |
| 2003 FY | 32.66 Million CNY | 0.0% |